Name: Regencell Bioscience Holdings Limited (RGC) Cash Flow Statement
Creator: FinSpry

Regencell Bioscience Holdings Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Regencell Bioscience Holdings Limited (RGC) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Operating Activities
Net Income	-3.58	-4.30	-5.87	-7.45	-1.35
Depreciation & Amortization	0.39	0.75	0.77	0.60	0.03
Stock Based Compensation	0.00	0.45	0.92	2.76	0.00
Change in Working Capital	0.02	-0.59	-0.51	-1.02	0.55
Change in Accounts Payable	0.00	0.00	-0.01	-0.07	0.08
Change in Other Working Capital	0.02	-0.59	-0.09	-1.02	0.55
Other Operating Activities	0.06	-0.31	-0.09	-0.16	0.00
Net Cash from Operating Activities	-3.11	-4.00	-4.96	-5.27	-0.77
Investing Activities
Capital Expenditures	-0.15	-0.01	-0.03	-0.78	0.00
Purchases of Investments	-32.48	5.25	-10.00	-10.00	0.00
Sales/Maturities of Investments	35.32	10.25	10.09	0.00	0.00
Net Cash from Investing Activities	2.69	5.24	0.06	-10.78	0.00
Financing Activities
Debt Repayment	0.00	0.00	0.00	-0.43	0.00
Common Stock Issued	0.00	0.00	0.00	22.67	0.00
Other Financing Activities	0.00	0.10	0.13	0.16	-0.17
Net Cash from Financing Activities	0.00	0.10	0.13	22.41	0.44
Summary
Effect of Forex Changes on Cash	-0.11	0.05	-0.08	0.00	0.00
Net Change in Cash	-0.54	1.40	-4.77	6.36	-0.33
Cash at Beginning of Period	2.96	1.56	6.42	0.06	0.39
Cash at End of Period	2.42	2.96	1.56	6.42	0.06
Free Cash Flow	-3.27	-4.01	-4.99	-6.05	-0.77